Bridget Fahy

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Teladoc Health Inc
    Date added:
    01/17/2023
    Date updated:
    01/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Guardant Health, inc
    Date added:
    01/17/2023
    Date updated:
    01/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Fulgent Genetics, Inc
    Date added:
    01/17/2023
    Date updated:
    01/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Seagen, Inc
    Date added:
    01/17/2023
    Date updated:
    01/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Intuitive Surgical, Inc
    Date added:
    01/17/2023
    Date updated:
    01/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    HCA Healthcare, Inc
    Date added:
    01/17/2023
    Date updated:
    01/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    DexCom, Inc
    Date added:
    01/17/2023
    Date updated:
    01/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Neurocrine Biosciences
    Date added:
    01/17/2023
    Date updated:
    01/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Biogen, Inc
    Date added:
    01/17/2023
    Date updated:
    01/17/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Editas Medicine, Inc
    Date added:
    01/17/2023
    Date updated:
    01/17/2023

Pages

Return to 2023 Summit on Cancer Health Disparities: Reframing and Addressing Barriers to Adoption of Precision Oncology